haloperidol decanoate has been researched along with Dyskinesia, Drug-Induced in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (26.32) | 18.7374 |
1990's | 6 (31.58) | 18.2507 |
2000's | 6 (31.58) | 29.6817 |
2010's | 2 (10.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Busanello, A; de Freitas, CM; de Moraes Reis, E; Fachinetto, R; Ferreira, J; Figueira, FH; Leal, CQ; Mello, CF; Röpke, J; Villarinho, JG | 1 |
Barcelos, RC; Benvegnú, DM; Boufleur, N; Bürger, ME; Emanuelli, T; Müller, LG; Pase, C; Reckziegel, P | 1 |
Kapur, S; Nobrega, JN; Remington, G; Turrone, P | 1 |
Agrawal, SM; McCullumsmith, RE; Meador-Woodruff, JH; Stincic, TL | 1 |
Aamo, TO; Andreassen, OA; Beal, MF; Ferrante, RJ; Jørgensen, HA | 1 |
Buschman, HP; Hariz, M; Kölling, P; Lenders, MW; Steur, EN; Vergouwen, MD | 1 |
Kantrowitz, JT; Srihari, VH; Tek, C | 1 |
Mori, A | 1 |
Harada, T; Kashihara, K; Sato, M | 1 |
Jaffe, E; Reider, R; Sharif, Z; Trémeau, F | 1 |
Egan, MF; Hyde, TM; Kleinman, JE; Weinberger, DR; Wing, LL; Wyatt, RJ | 1 |
Baca, SM; Egan, MF; Hamid, EH; Hyde, TM | 1 |
Andrén, PE; Gunne, L; Klintenberg, R | 1 |
Eklund, K; Forsman, A | 1 |
Cookson, JC | 1 |
Johansson, P | 1 |
Annable, L; Campbell, W; Chouinard, G | 1 |
Knudsen, P | 1 |
Bollen, J; De Cuyper, H; van Praag, HM; Verstraeten, D | 1 |
1 review(s) available for haloperidol decanoate and Dyskinesia, Drug-Induced
Article | Year |
---|---|
[Recent advances in clinical psychopharmacology].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benzamides; Carbamazepine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Kinetics; Lithium; Psychopharmacology; Schizophrenia | 1984 |
3 trial(s) available for haloperidol decanoate and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Radioimmunoassay; Recurrence; Schizophrenia | 1991 |
Side effects during long-term treatment with depot antipsychotic medication.
Topics: Akathisia, Drug-Induced; Delayed-Action Preparations; Double-Blind Method; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Parkinson Disease, Secondary; Psychomotor Agitation; Recurrence; Schizophrenia | 1991 |
A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1989 |
15 other study(ies) available for haloperidol decanoate and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats.
Topics: Animals; Antipsychotic Agents; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Endocannabinoids; Haloperidol; Male; Mastication; Movement; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Treatment Outcome | 2014 |
Effects of omega-3 essential fatty acids (omega-3 EFAs) on motor disorders and memory dysfunction typical neuroleptic-induced: behavioral and biochemical parameter.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Disease Models, Animal; Dyskinesia, Drug-Induced; Fatty Acids, Omega-3; Haloperidol; Male; Maze Learning; Memory Disorders; Movement Disorders; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Time Factors | 2010 |
The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
Topics: Animals; Antipsychotic Agents; Cerebellum; Corpus Striatum; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Haloperidol; Male; Mastication; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior | 2003 |
Differential effects of antipsychotics on haloperidol-induced vacuous chewing movements and subcortical gene expression in the rat.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Dyskinesia, Drug-Induced; Gene Expression; Haloperidol; In Situ Hybridization; Injections, Intramuscular; Male; Mastication; Olanzapine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate; RNA, Messenger | 2003 |
Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats.
Topics: Aging; Analysis of Variance; Animals; Behavior, Animal; Cell Count; Disease Models, Animal; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Haloperidol; Mastication; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substantia Nigra; Time; Time Factors | 2003 |
Long term results of unilateral posteroventral pallidotomy for antipsychotic drug induced tardive dyskinesia.
Topics: Athetosis; Chorea; Clopenthixol; Delayed-Action Preparations; Dominance, Cerebral; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Follow-Up Studies; Globus Pallidus; Haloperidol; Humans; Male; Middle Aged; Myoclonus; Neurologic Examination; Outcome Assessment, Health Care; Schizophrenia; Treatment Outcome | 2005 |
Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot.
Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Middle Aged; Piperazines; Quinolones; Remission Induction; Schizophrenia; Substance-Related Disorders | 2007 |
[Neuroleptic-induced dopaminergic supersensitivity following intermittent and continuous haloperidol administrations in rats].
Topics: Animals; Dyskinesia, Drug-Induced; Haloperidol; Male; Rats; Receptors, Dopamine | 1984 |
Clozapine in tardive Tourette syndrome.
Topics: Adult; Antipsychotic Agents; Clozapine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Injections, Intramuscular; Male; Neurologic Examination; Schizophrenia; Schizophrenic Psychology; Social Behavior; Substance Withdrawal Syndrome; Tourette Syndrome | 1995 |
Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.
Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dyskinesia, Drug-Induced; Haloperidol; Male; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley | 1995 |
Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia.
Topics: Animals; Antipsychotic Agents; Corpus Striatum; Dizocilpine Maleate; Down-Regulation; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Haloperidol; Male; Mastication; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 1998 |
Tardive dyskinesia model in the common marmoset.
Topics: Animals; Biperiden; Callithrix; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Female; Haloperidol; Male; Neurologic Examination; Parkinsonian Disorders | 2002 |
Methylazoxymethanol (MAM)-induced brain lesion and oral dyskinesia in rats.
Topics: Animals; Azo Compounds; Behavior, Animal; Brain Diseases; Corpus Striatum; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Glutamate Decarboxylase; Haloperidol; Methylazoxymethanol Acetate; Pregnancy; Rats; Substantia Nigra | 1990 |
Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations.
Topics: Administration, Oral; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Haloperidol; Humans; Kinetics; Long-Term Care; Patient Compliance; Perphenazine; Schizophrenia; Schizophrenic Psychology; Thiazines | 1985 |
Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration.
Topics: Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Kinetics; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders | 1986 |